Oracle Investment Management »

Teladoc shares owned by Oracle Investment Management

Quarter-by-quarter ownership of Teladoc (TDOC) shares owned by Oracle Investment Management from 13F filings

Historical chart of Oracle Investment Management investment in Teladoc

Tip: Access up to 7 years of quarterly data

All positions including Teladoc held by Oracle Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Teladoc by Oracle Investment Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $2.4M 113k 21.55

More positions owned by Oracle Investment Management

Biohaven (BHVN)
Pacific Biosciences Calif In Call Call Option
Teladoc Health Call Call Option
Pacific Biosciences of California (PACB)
Quidel Corp (QDEL)
Quidelortho Corp Call Call Option
Eyepoint Pharmaceuticals Com New (EYPT)
Springworks Therapeutics Call Call Option
Ardelyx Call Call Option
Springworks Therapeutics (SWTX)
Ardelyx (ARDX)
Eyepoint Pharmaceuticals Call Call Option
Forian Ord (FORA)
Biohaven Call Call Option
BioCryst Pharmaceuticals (BCRX)

View all positions for Oracle Investment Management

Top funds holding Teladoc

Vanguard Group
ARK Investment Management
Nikko Asset Management Americas
Sumitomo Mitsui Trust Holdings
Citadel Advisors
Dimensional Fund Advisors
Millennium Management
Man Group
Charles Schwab Investment Management
Baillie Gifford & Co
Point72 Asset Management
Credit Suisse
Bnp Paribas Arbitrage, Snc
Bank of New York Mellon
UBS Group

View all funds holding Teladoc